Historically, when PCa was suspected, diagnosis was based on an elevated prostate-specific antigen (PSA), abnormal digital rectal examination, and transrectal ultrasound (TRUS) images, all known to have low sensitivity and specificity for cancer diagnosis. Here, KLK3 is linked to posterior cortical atrophy.